wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52655906-E472D9DB-E336-4633-A0CF-E087AD93F1C7
Q52655906-E472D9DB-E336-4633-A0CF-E087AD93F1C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52655906-E472D9DB-E336-4633-A0CF-E087AD93F1C7
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
P2860
Q52655906-E472D9DB-E336-4633-A0CF-E087AD93F1C7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52655906-E472D9DB-E336-4633-A0CF-E087AD93F1C7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3fd179bd60d61eefb341624cd5c89715e728f83c
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.